One regimen showed an effectiveness of 90% when participants received a half dose, followed by a full dose at least one month apart.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
|
After Pfizer-BioNTech and Moderna, Oxford-AstraZeneca is announcing the results of the trials of its vaccine.